Insufficient scRNA-seq data for expression of USP18 at single-cell level.
Insufficient scRNA-seq data for expression of USP18 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 459.08 | 459 / 459 | 97% | 26.95 | 1088 / 1118 |
lung | 99% | 308.39 | 570 / 578 | 97% | 20.90 | 1116 / 1155 |
ovary | 93% | 137.68 | 167 / 180 | 100% | 40.33 | 428 / 430 |
thymus | 100% | 338.33 | 651 / 653 | 91% | 12.49 | 549 / 605 |
prostate | 98% | 171.28 | 241 / 245 | 92% | 12.15 | 460 / 502 |
esophagus | 98% | 182.48 | 1413 / 1445 | 91% | 15.35 | 167 / 183 |
uterus | 96% | 158.62 | 164 / 170 | 92% | 22.31 | 420 / 459 |
bladder | 100% | 154.86 | 21 / 21 | 85% | 15.02 | 430 / 504 |
skin | 95% | 179.55 | 1725 / 1809 | 89% | 20.97 | 421 / 472 |
brain | 92% | 119.95 | 2427 / 2642 | 91% | 12.58 | 640 / 705 |
stomach | 98% | 163.47 | 351 / 359 | 84% | 11.98 | 241 / 286 |
pancreas | 87% | 87.06 | 284 / 328 | 95% | 13.60 | 169 / 178 |
intestine | 96% | 134.91 | 931 / 966 | 84% | 11.64 | 441 / 527 |
kidney | 100% | 245.40 | 89 / 89 | 77% | 7.47 | 697 / 901 |
liver | 94% | 217.66 | 213 / 226 | 78% | 9.10 | 315 / 406 |
adrenal gland | 98% | 245.20 | 253 / 258 | 40% | 3.70 | 92 / 230 |
adipose | 100% | 511.69 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 253.48 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 31.34 | 44 / 45 |
blood vessel | 96% | 186.66 | 1287 / 1335 | 0% | 0 | 0 / 0 |
muscle | 93% | 116.94 | 743 / 803 | 0% | 0 | 0 / 0 |
heart | 90% | 111.27 | 777 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 70% | 6.95 | 56 / 80 |
lymph node | 0% | 0 | 0 / 0 | 62% | 12.46 | 18 / 29 |
peripheral blood | 49% | 603.35 | 454 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0035634 | Biological process | response to stilbenoid |
GO_0016579 | Biological process | protein deubiquitination |
GO_0060339 | Biological process | negative regulation of type I interferon-mediated signaling pathway |
GO_0050727 | Biological process | regulation of inflammatory response |
GO_0006508 | Biological process | proteolysis |
GO_0140374 | Biological process | antiviral innate immune response |
GO_0009617 | Biological process | response to bacterium |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0019785 | Molecular function | ISG15-specific peptidase activity |
GO_0005515 | Molecular function | protein binding |
GO_0004843 | Molecular function | cysteine-type deubiquitinase activity |
GO_0060090 | Molecular function | molecular adaptor activity |
Gene name | USP18 |
Protein name | Ubl carboxyl-terminal hydrolase 18 (EC 3.4.19.12) (43 kDa ISG15-specific protease) (hUBP43) (ISG15-specific-processing protease) (Ubl thioesterase 18) Ubiquitin specific peptidase 18 |
Synonyms | ISG43 |
Description | FUNCTION: Interferon-induced ISG15-specific protease that plays a crucial role for maintaining a proper balance of ISG15-conjugated proteins in cells . Regulates protein ISGylation by efficiently cleaving ISG15 conjugates linked via isopeptide bonds. Regulates T-cell activation and T-helper 17 (Th17) cell differentiation by deubiquitinating TAK1, likely to keep TAK1-TAB complexes in steady conditions . In turn, restricts activation of NF-kappa-B, NFAT, and JNK as well as expression of IL2 in T-cells after TCR activation . Acts as a molecular adapter with USP20 to promote innate antiviral response through deubiquitinating STING1 . Involved also in the negative regulation of the inflammatory response triggered by type I interferon . Upon recruitment by STAT2 to the type I interferon receptor subunit IFNAR2 interferes with the assembly of the ternary interferon-IFNAR1-IFNAR2 complex and acts as a negative regulator of the type I interferon signaling pathway . .; FUNCTION: [Isoform 2]: Has enzymatic activity similar to isoform 1 and interferes with type I interferon signaling. Major deISGylation enzyme for nuclear proteins . . |
Accessions | A0A8V8TMN0 Q9UMW8 ENST00000215794.8 [Q9UMW8-1] ENST00000699060.1 |